IL-13 anticorps (N-Term)
-
- Antigène Voir toutes IL-13 (IL13) Anticorps
- IL-13 (IL13) (Interleukin 13 (IL13))
-
Épitope
- N-Term
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp IL-13 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Specificité
- IL13 Antibody detects endogenous levels of total IL13.
- Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogène
- A synthesized peptide derived from human IL13, corresponding to a region within N-terminal amino acids.
- Isotype
- IgG
- Top Product
- Discover our top product IL13 Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000, IHC 1:50-1:200, ELISA(peptide) 1:20000-1:40000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
- Date de péremption
- 12 months
-
- Antigène
- IL-13 (IL13) (Interleukin 13 (IL13))
- Autre désignation
- IL13 (IL13 Produits)
- Synonymes
- anticorps IL13, anticorps IL-13, anticorps P600, anticorps Il-13, anticorps L13, anticorps interleukin 13, anticorps IL13, anticorps Il13
- Sujet
-
Description: Cytokine (PubMed:8096327, PubMed:8097324). Inhibits inflammatory cytokine production (PubMed:8096327). Synergizes with IL2 in regulating interferon-gamma synthesis (PubMed:8096327). May be critical in regulating inflammatory and immune responses (PubMed:8096327, PubMed:8097324). Positively regulates IL31RA expression in macrophages (By similarity).
Gene: IL13
- Poids moléculaire
- 16kDa
- ID gène
- 3596
- UniProt
- P35225
- Pathways
- Signalistation JAK/STAT, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Proton Transport
-